DiaSorin S.p.A. Overview
Pro stress-test →DiaSorin develops and manufactures a broad portfolio of in vitro diagnostics used for detecting pathogens and contamination of samples from the human body, as well as used in industrial settings such as food and water contamination testing. The company operates a dual-channel business model selling diagnostic machines to laboratories while providing recurring revenue from consumables needed for diagnostics.
Strategic Profile
Pro stress-test →The Group operates across five continents through 35 companies, 4 branches, 10 manufacturing facilities, and 9 research and development centers. The company operates three segments: immunodiagnostics (66% of sales), molecular diagnostics (17%), and licensed technologies (14%). Notable brands include LIAISON and Verigene systems, along with xMAP technology.
Competitive Landscape
Pro stress-test →Key competitors include Bio-Rad Laboratories, QuidelOrtho, Revvity, Randox, and BioMérieux. DiaSorin maintains differentiation through its proprietary automation platforms, global distribution network, and integrated equipment-plus-reagent business model. The competitive landscape remains fragmented with major players competing on technology innovation, geographic reach, and product breadth.
Industry Context
DiaSorin S.p.A. operates in In Vitro Diagnostics / Medical Diagnostics.
Key facts
Founded: 1968 · Headquarters: Saluggia, Italy · Employees: 3,280 · Revenue: $1.32B · Market cap: $4.68B